AbCellera Biologics Inc.
ABCL
Rangering i aksjer
#4059
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Aksjekurs
$12.29
Sist synkronisert: 2026-10-21
Markedsverdi
$3.98B
Endring (1 dag)
4.95%
Endring (1 år)
124.68%
Land
CA
Handel AbCellera Biologics Inc. (ABCL)
Kategori
Healthcare
Aksjeprishistorikk for AbCellera Biologics Inc. (ABCL)
Høyeste sluttskurs: $12.67 den 2026-10-01
Laveste sluttskurs: $45.73 den 2020-12-01
Laveste sluttskurs: $45.73 den 2020-12-01
Aksjeprishistorikk for AbCellera Biologics Inc. fra 2020 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 69.44% |
| 2025 | 23.13% |
| 2024 | -44.83% |
| 2023 | -50.84% |
| 2022 | -25.40% |
| 2021 | -68.67% |
| 2020 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.95 | -3.70% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
